RheumShorts: Methotrexate, Basiliximab, and Norwegian Lyme (CME/CE)

(MedPage Today) -- Subcutaneous methotrexate can be given at higher doses than in the oral route, while maintaining bioavailability, which could make for better tolerance and better adherence to treatment guidelines, a new study suggested.
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news